| Item Type | Name |
|
Academic Article
|
Treatment of Epstein-Barr virus-associated malignancies with specific T cells.
|
|
Academic Article
|
Immunotherapy for Hodgkin's disease.
|
|
Academic Article
|
Large-scale expansion of dendritic cell-primed polyclonal human cytotoxic T-lymphocyte lines using lymphoblastoid cell lines for adoptive immunotherapy.
|
|
Academic Article
|
Comparable outcomes of matched-related and alternative donor stem cell transplantation for pediatric severe aplastic anemia.
|
|
Academic Article
|
The generation and characterization of LMP2-specific CTLs for use as adoptive transfer from patients with relapsed EBV-positive Hodgkin disease.
|
|
Academic Article
|
Immunotherapeutic options for Epstein-Barr virus-associated lymphoproliferative disease following transplantation.
|
|
Academic Article
|
Molecular transfer of CD40 and OX40 ligands to leukemic human B cells induces expansion of autologous tumor-reactive cytotoxic T lymphocytes.
|
|
Academic Article
|
T cells redirected against CD70 for the immunotherapy of CD70-positive malignancies.
|
|
Academic Article
|
Good manufacturing practice-grade cytotoxic T lymphocytes specific for latent membrane proteins (LMP)-1 and LMP2 for patients with Epstein-Barr virus-associated lymphoma.
|
|
Academic Article
|
Cellular immunotherapy for high-grade glioma.
|
|
Academic Article
|
Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States.
|
|
Academic Article
|
Expansion of T cells targeting multiple antigens of cytomegalovirus, Epstein-Barr virus and adenovirus to provide broad antiviral specificity after stem cell transplantation.
|
|
Academic Article
|
Rapidly generated multivirus-specific cytotoxic T lymphocytes for the prophylaxis and treatment of viral infections.
|
|
Academic Article
|
Administration of latent membrane protein 2-specific cytotoxic T lymphocytes to patients with relapsed Epstein-Barr virus-positive lymphoma.
|
|
Academic Article
|
Treatment of solid organ transplant recipients with autologous Epstein Barr virus-specific cytotoxic T lymphocytes (CTLs).
|
|
Academic Article
|
T cell therapies.
|
|
Academic Article
|
Contact-activated monocytes: efficient antigen presenting cells for the stimulation of antigen-specific T cells.
|
|
Academic Article
|
Dendritic cell function after gene transfer with adenovirus-calcium phosphate co-precipitates.
|
|
Academic Article
|
Regression of experimental medulloblastoma following transfer of HER2-specific T cells.
|
|
Academic Article
|
Successful treatment of stem cell graft failure in pediatric patients using a submyeloablative regimen of campath-1H and fludarabine.
|
|
Academic Article
|
Enhancing the in vivo expansion of adoptively transferred EBV-specific CTL with lymphodepleting CD45 monoclonal antibodies in NPC patients.
|
|
Academic Article
|
Immunotherapy for osteosarcoma: genetic modification of T cells overcomes low levels of tumor antigen expression.
|
|
Academic Article
|
piggyBac transposon/transposase system to generate CD19-specific T cells for the treatment of B-lineage malignancies.
|
|
Academic Article
|
HER2-specific T cells target primary glioblastoma stem cells and induce regression of autologous experimental tumors.
|
|
Academic Article
|
Adverse events following infusion of T cells for adoptive immunotherapy: a 10-year experience.
|
|
Academic Article
|
Crosstalk between medulloblastoma cells and endothelium triggers a strong chemotactic signal recruiting T lymphocytes to the tumor microenvironment.
|
|
Academic Article
|
Adoptive transfer of EBV-specific T cells results in sustained clinical responses in patients with locoregional nasopharyngeal carcinoma.
|
|
Academic Article
|
A Th1-inducing adenoviral vaccine for boosting adoptively transferred T cells.
|
|
Academic Article
|
T cells redirected to EphA2 for the immunotherapy of glioblastoma.
|
|
Academic Article
|
Immunotherapeutic strategies to prevent and treat human herpesvirus 6 reactivation after allogeneic stem cell transplantation.
|
|
Academic Article
|
PiggyBac-mediated cancer immunotherapy using EBV-specific cytotoxic T-cells expressing HER2-specific chimeric antigen receptor.
|
|
Academic Article
|
Cytotoxic T lymphocytes simultaneously targeting multiple tumor-associated antigens to treat EBV negative lymphoma.
|
|
Academic Article
|
Aggressive peripheral CD70-positive T-cell lymphoma associated with severe chronic active EBV infection.
|
|
Academic Article
|
Generation of polyclonal CMV-specific T cells for the adoptive immunotherapy of glioblastoma.
|
|
Academic Article
|
In vivo expansion of LMP 1- and 2-specific T-cells in a patient who received donor-derived EBV-specific T-cells after allogeneic stem cell transplantation.
|
|
Academic Article
|
Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer.
|
|
Academic Article
|
TILling head and neck cancer for cell therapy.
|
|
Concept
|
Antigens, Differentiation, T-Lymphocyte
|
|
Concept
|
T-Lymphocytes, Cytotoxic
|
|
Concept
|
Lymphocyte Activation
|
|
Concept
|
Lymphocyte Depletion
|
|
Concept
|
CD8-Positive T-Lymphocytes
|
|
Concept
|
Lymphocyte Count
|
|
Concept
|
CD4-Positive T-Lymphocytes
|
|
Concept
|
B-Lymphocytes
|
|
Concept
|
T-Lymphocyte Subsets
|
|
Concept
|
Epitopes, T-Lymphocyte
|
|
Concept
|
Lymphocytes, Tumor-Infiltrating
|
|
Concept
|
T-Lymphocytes
|
|
Concept
|
Lymphocyte Transfusion
|
|
Academic Article
|
Antitumor effects of chimeric receptor engineered human T cells directed to tumor stroma.
|
|
Academic Article
|
Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma.
|
|
Academic Article
|
Adoptive T-cell transfer and chemotherapy in the first-line treatment of metastatic and/or locally recurrent nasopharyngeal carcinoma.
|
|
Academic Article
|
T-cell engager-armed oncolytic vaccinia virus significantly enhances antitumor therapy.
|
|
Academic Article
|
Safety and clinical efficacy of rapidly-generated trivirus-directed T cells as treatment for adenovirus, EBV, and CMV infections after allogeneic hematopoietic stem cell transplant.
|
|
Academic Article
|
Design and development of therapies using chimeric antigen receptor-expressing T cells.
|
|
Academic Article
|
A vaccine that co-targets tumor cells and cancer associated fibroblasts results in enhanced antitumor activity by inducing antigen spreading.
|
|
Academic Article
|
Sustained complete responses in patients with lymphoma receiving autologous cytotoxic T lymphocytes targeting Epstein-Barr virus latent membrane proteins.
|
|
Academic Article
|
Complementation of antigen-presenting cells to generate T lymphocytes with broad target specificity.
|
|
Academic Article
|
Genetically modified T-cell therapy for osteosarcoma.
|
|
Academic Article
|
T cells redirected to interleukin-13Ra2 with interleukin-13 mutein--chimeric antigen receptors have anti-glioma activity but also recognize interleukin-13Ra1.
|
|
Academic Article
|
T-cell immunotherapy: looking forward.
|
|
Academic Article
|
Toward immunotherapy with redirected T cells in a large animal model: ex vivo activation, expansion, and genetic modification of canine T cells.
|
|
Academic Article
|
Engager T cells: a new class of antigen-specific T cells that redirect bystander T cells.
|
|
Academic Article
|
Adoptive cell therapy for sarcoma.
|
|
Academic Article
|
Human Epidermal Growth Factor Receptor 2 (HER2) -Specific Chimeric Antigen Receptor-Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma.
|
|
Academic Article
|
Response to "in vivo secretion of anti-CD3 ? anti-tumor bispecific antibodies by gene-modified cells: over a decade of T-cell engagement".
|
|
Academic Article
|
Characterization and Functional Analysis of scFv-based Chimeric Antigen Receptors to Redirect T Cells to IL13Ra2-positive Glioma.
|
|
Academic Article
|
Adoptive T-Cell Immunotherapy.
|
|
Academic Article
|
T cells expressing CD19-specific Engager Molecules for the Immunotherapy of CD19-positive Malignancies.
|
|
Academic Article
|
Tandem CAR T cells targeting HER2 and IL13Ra2 mitigate tumor antigen escape.
|
|
Academic Article
|
Redirecting T Cells to Glypican-3 with 4-1BB Zeta Chimeric Antigen Receptors Results in Th1 Polarization and Potent Antitumor Activity.
|
|
Academic Article
|
CD123-Engager T Cells as a Novel Immunotherapeutic for Acute Myeloid Leukemia.
|
|
Academic Article
|
EBV-Directed T Cell Therapeutics for EBV-Associated Lymphomas.
|
|
Academic Article
|
HER2-Specific Chimeric Antigen Receptor-Modified Virus-Specific T Cells for Progressive Glioblastoma: A Phase 1 Dose-Escalation Trial.
|
|
Academic Article
|
Transgenic Expression of IL15 Improves Antiglioma Activity of IL13Ra2-CAR T Cells but Results in Antigen Loss Variants.
|
|
Academic Article
|
Off-the-Shelf Virus-Specific T Cells to Treat BK Virus, Human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections After Allogeneic Hematopoietic Stem-Cell Transplantation.
|
|
Academic Article
|
Inducible Activation of MyD88 and CD40 in CAR T Cells Results in Controllable and Potent Antitumor Activity in Preclinical Solid Tumor Models.
|
|
Academic Article
|
Constitutive Signaling from an Engineered IL7 Receptor Promotes Durable Tumor Elimination by Tumor-Redirected T Cells.
|
|
Academic Article
|
CAR T-cell therapy for glioblastoma: ready for the next round of clinical testing?
|
|
Academic Article
|
Treatment of Acute Myeloid Leukemia with T Cells Expressing Chimeric Antigen Receptors Directed to C-type Lectin-like Molecule 1.
|
|
Academic Article
|
Adenovirotherapy Delivering Cytokine and Checkpoint Inhibitor Augments CAR T Cells against Metastatic Head and Neck Cancer.
|
|
Academic Article
|
Tumor-Specific T-Cells Engineered to Overcome Tumor Immune Evasion Induce Clinical Responses in Patients With Relapsed Hodgkin Lymphoma.
|
|
Academic Article
|
HBsAg-redirected T cells exhibit antiviral activity in HBV-infected human liver chimeric mice.
|
|
Academic Article
|
Redirecting T cells to hematological malignancies with bispecific antibodies.
|
|
Academic Article
|
Advances in immunotherapy for pediatric acute myeloid leukemia.
|
|
Academic Article
|
CD28 and 41BB Costimulation Enhances the Effector Function of CD19-Specific Engager T Cells.
|
|
Academic Article
|
Adoptive Transfer of IL13Ra2-Specific Chimeric Antigen Receptor T Cells Creates a Pro-inflammatory Environment in Glioblastoma.
|
|
Academic Article
|
Antibody with Infinite Affinity for In Vivo Tracking of Genetically Engineered Lymphocytes.
|
|
Academic Article
|
Epstein-Barr Virus (EBV)-derived BARF1 encodes CD4- and CD8-restricted epitopes as targets for T-cell immunotherapy.
|
|
Academic Article
|
The Landscape of CAR T Cells Beyond Acute Lymphoblastic Leukemia for Pediatric Solid Tumors.
|
|
Academic Article
|
NK Cells Expressing a Chimeric Activating Receptor Eliminate MDSCs and Rescue Impaired CAR-T Cell Activity against Solid Tumors.
|
|
Academic Article
|
EBV/LMP-specific T cells maintain remissions of T- and B-cell EBV lymphomas after allogeneic bone marrow transplantation.
|
|
Academic Article
|
Genetic Modification Strategies to Enhance CAR T Cell Persistence for Patients With Solid Tumors.
|
|
Academic Article
|
Peripheral T cell cytotoxicity predicts T cell function in the tumor microenvironment.
|
|
Academic Article
|
Engineering for Success: Approaches to Improve Chimeric Antigen Receptor T?Cell Therapy for Solid Tumors.
|
|
Academic Article
|
Lentiviral Gene Therapy Combined with Low-Dose Busulfan in Infants with SCID-X1.
|
|
Academic Article
|
"Mini" bank of only 8 donors supplies CMV-directed T cells to diverse recipients.
|
|
Academic Article
|
Improved survival rate in T-cell depleted haploidentical hematopoietic cell transplantation over the last 15 years at a single institution.
|
|
Academic Article
|
Genetically Modified T-Cell Therapy for Osteosarcoma: Into the Roaring 2020s.
|
|
Academic Article
|
Rewriting History: Epigenetic Reprogramming of CD8+ T Cell Differentiation to Enhance Immunotherapy.
|
|
Academic Article
|
Tumor response and endogenous immune reactivity after administration of HER2 CAR T cells in a child with metastatic rhabdomyosarcoma.
|
|
Academic Article
|
Chimeric Antigen Receptor-modified T cells targeting EphA2 for the immunotherapy of paediatric bone tumours.
|
|
Academic Article
|
CAR T Cell Therapy for Solid Tumors: Bright Future or Dark Reality?
|
|
Academic Article
|
MyD88/CD40 signaling retains CAR T cells in a less differentiated state.
|
|
Academic Article
|
Clinical effects of administering leukemia-specific donor T cells to patients with AML/MDS after allogeneic transplant.
|
|
Academic Article
|
Cell-surface antigen profiling of pediatric brain tumors: B7-H3 is consistently expressed and can be targeted via local or systemic CAR T-cell delivery.
|
|
Academic Article
|
Antitumor Effects of CAR T Cells Redirected to the EDB Splice Variant of Fibronectin.
|
|
Academic Article
|
Oncolytic adenovirus and gene therapy with EphA2-BiTE for the treatment of pediatric high-grade gliomas.
|
|
Academic Article
|
The role of exhaustion in CAR T cell therapy.
|
|
Academic Article
|
CD70-specific CAR T cells have potent activity against acute myeloid leukemia without HSC toxicity.
|
|
Academic Article
|
Deleting DNMT3A in CAR T cells prevents exhaustion and enhances antitumor activity.
|
|
Academic Article
|
CD19-CAR T?cells undergo exhaustion DNA methylation programming in patients with acute lymphoblastic leukemia.
|
|
Academic Article
|
Unifying heterogeneous expression data to predict targets for CAR-T cell therapy.
|
|
Academic Article
|
Development of a cGMP-compliant process to manufacture donor-derived, CD45RA-depleted memory CD19-CAR T cells.
|
|
Academic Article
|
CAR T cells redirected to cell surface GRP78 display robust anti-acute myeloid leukemia activity and do not target hematopoietic progenitor cells.
|
|
Academic Article
|
B7-H3 Specific CAR T Cells for the Naturally Occurring, Spontaneous Canine Sarcoma Model.
|
|
Academic Article
|
Preferential expansion of CD8+ CD19-CAR T cells postinfusion and the role of disease burden on outcome in pediatric B-ALL.
|
|
Academic Article
|
Transgenic Expression of IL15 Retains CD123-Redirected T Cells in a Less Differentiated State Resulting in Improved Anti-AML Activity in Autologous AML PDX Models.
|
|
Academic Article
|
CAR T?cell therapy for solid tumors: Fatal attraction requires adhesion.
|
|
Academic Article
|
Common Trajectories of Highly Effective CD19-Specific CAR T Cells Identified by Endogenous T-cell Receptor Lineages.
|
|
Academic Article
|
Improving the anti-acute myeloid leukemia activity of CD123-specific engager T cells by MyD88 and CD40 costimulation.
|
|
Academic Article
|
Allogeneic CD34+ selected hematopoietic stem cell boost following CAR T-cell therapy in a patient with prolonged cytopenia and active infection.
|
|
Academic Article
|
CD47 expression is critical for CAR T-cell survival in vivo.
|
|
Academic Article
|
IL15 modification enables CAR T cells to act as a dual targeting agent against tumor cells and myeloid-derived suppressor cells in GBM.
|
|
Academic Article
|
A tour de force provides novel insights into CD19-CAR T?cell resistance mechanisms.
|
|
Academic Article
|
RASA2 ablation in T cells boosts antigen sensitivity and long-term function.
|
|
Academic Article
|
CD19 CAR T-cell therapy demonstrates activity against extramedullary disease in pediatric patients with B-ALL.
|
|
Academic Article
|
Preparation of cryopreserved chimeric antigen receptor T cells for the locoreogional delivery to the neural axis.
|
|
Academic Article
|
INSPIRED Symposium Part 4B: Chimeric Antigen Receptor T Cell Correlative Studies-Established Findings and Future Priorities.
|
|
Academic Article
|
Integrome signatures of lentiviral gene therapy for SCID-X1 patients.
|
|
Academic Article
|
Latent human herpesvirus 6 is reactivated in CAR T cells.
|
|
Academic Article
|
CAR T-cell Design-dependent Remodeling of the Brain Tumor Immune Microenvironment Modulates Tumor-associated Macrophages and Anti-glioma Activity.
|
|
Academic Article
|
LILRB3 Modulates Acute Myeloid Leukemia Progression and Acts as an Effective Target for CAR T-cell Therapy.
|
|
Academic Article
|
Preventing relapse after CD19 CAR T-cell therapy for pediatric ALL: the role of transplant and enhanced CAR T cells.
|
|
Academic Article
|
Is immune escape in the rearview mirror?
|
|
Academic Article
|
Peptide-scFv antigen recognition domains effectively confer CAR T?cell multiantigen specificity.
|
|
Academic Article
|
DNAJB1-PRKACA fusion neoantigens elicit rare endogenous T?cell responses that potentiate cell therapy for fibrolamellar carcinoma.
|
|
Academic Article
|
Secondary bone marrow graft loss after third-party virus-specific T cell infusion: Case report of a rare complication.
|